NOVARTIS PHARMA AG PATENTS FACING OPPOSITIONS
Top patents of NOVARTIS PHARMA AG facing oppositions at the European Patent Office (EPO)
| Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
|---|---|---|---|---|---|
| EP3351246B8 | 18 Sep, 2019 | Rapamycin Derivative For The Treatment Of A Solid Tumor Associated With Deregulated Angiogenesis | Feb, 2022 | 10 | |
| EP3342411B1 | 21 Aug, 2019 | Rapamycin Derivative For Treating Pancreas Cancer | Feb, 2022 | 10 | |
| EP2784084B2 | 04 Oct, 2023 | Il-17 A/F Heterologous Polypeptides And Therapeutics Uses Thereof | Jun, 2024 | 4 | |
| EP3345602B1 | 06 Apr, 2022 | Rapamycin Derivative For Treating Advanced Solid Tumours | Feb, 2022 | 3 |